Sentence examples for making patents from inspiring English sources

(The "trolls" argue that by making patents valued they are helping to create a market in invention that will encourage inventors).

But it is a setback for the drug industry, which often seeks new patents for minor tweaks to existing inventions, such as combining one drug with another.The ruling is just one in a string of recent cases in which the Supreme Court has sought to reverse the trend towards making patents easier to obtain and enforce.

So fluid are their markets, and so weak the historical patent-protection in them, that bosses often prefer to keep things in the dark and come up with the next innovation as necessary to stay ahead of the competition.Even in developed markets, the acceleration of innovation is making patents less relevant.

The current approach of making patents harder to get and of lesser value is not a true solution and is a classic case of throwing the baby out with the bathwater.

One would be to have the officials in charge of making patent determinations reconsider their decisions.

Meeting that test often requires a jury trial, making patent litigation prolonged and expensive.

In Washington Park, a three-minute walk away, the statue of Seth Boyden, who refined a process for making patent leather, struck a stalwart pose for nobody.

On the other hand, making patent law more effective could encourage precisely the sort of innovation that will deliver the next generation of devices, whatever they may be, for music distribution.

In an April 2007 decision, the court raised the bar for what's considered "obvious" in patent claims effectively making patent awards tougher to win and setting the stage for challenges to existing patents.

To be able to make a real difference in this area, further research and an efficient and sustainable infrastructure for making patent-derived data freely accessible to the scientific community is needed.

But Shasun figures its two U.K. factories making patented drugs for customers such as Eli Lilly and GlaxoSmithkline will give it a foothold in both America and Europe for becoming a one-stop back support researching, developing and making drugs for Big Pharma.